Amitifadine Hydrochloride

阿米发定

Report date: 2024/05/23 20:00:04
NME

Base Information

Drug NameAmitifadine Hydrochloride
Drug Alias NameamitifadineamitifadinaamitifadinumEB-1010DOV-21947
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsDopamine transporterNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRomaniaSerbia
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEuthymics Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEuthymics Bioscience Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG